Michael Scolaro

Michael Scolaro

Sep 10, 2017

Group 6 Copy 180
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we utilize natural bat colony behavior as a vaccination strategy?

    Bats are one of the most prolific and ecologically important groups of mammals on the planet, but they are often...

    New bioactive peptides from skin of a colombian frog

    The search for alternative antibiotics is on, due to widespread resistance to current antibiotics. We will use...

    Postpartum Mental Health Needs of Hispanic Mothers

    Postpartum mood disorders represent a critical public health issue affecting mothers and their children. Increased...

    Backer Badge Funded